Electronic Common Technical Document (eCTD)

Автор: U.S. Food and Drug Administration

Загружено: 2021-07-29

Просмотров: 13557

Описание:

Jonathan Resnick, project management officer for the Division of Data Management Services and Solutions, discusses the Electronic Common Technical Document (eCTD), recent updates, common errors, frequently asked questions, and information about the Technical Rejection Criteria for Study Data (TRC).

Learn More at: https://www.fda.gov/drugs/regulatory-...

_______________________________ 
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  
 
Upcoming Training - https://www.fda.gov/cdersbia
SBIA Listserv - https://public.govdelivery.com/accoun...
SBIA 2021 Playlist -    • 2021 CDER Small Business and Industry Assi...
SBIA LinkedIn -   / cder-small-business-and-industry-assistance
SBIA Training Resources - https://www.fda.gov/cdersbialearn
Twitter -   / fda_drug_info
Email - [email protected]
Phone - (301) 796-6707 I (866) 405-5367

Electronic Common Technical Document (eCTD)

Доступные форматы для скачивания:

Скачать видео mp4

Информация по загрузке:

Скачать аудио mp3

Похожие видео

CMC Considerations for Biotechnology Product Development: A Regulatory Perspective

CMC Considerations for Biotechnology Product Development: A Regulatory Perspective

CDER NextGen Portal

CDER NextGen Portal

Understanding FDA Inspections and Data

Understanding FDA Inspections and Data

Electronic Common Technical Document (eCTD) and Study Data (7of15) RedI – May 29-30, 2019

Electronic Common Technical Document (eCTD) and Study Data (7of15) RedI – May 29-30, 2019

FDA Study Data Technical Rejection Criteria (TRC): What you need to know!

FDA Study Data Technical Rejection Criteria (TRC): What you need to know!

Medical Device Quality Management System Regulation Risk Management

Medical Device Quality Management System Regulation Risk Management

FDA Direct: Catching Up on Agency Reforms

FDA Direct: Catching Up on Agency Reforms

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Drug Master File (DMF) Submissions on New FDA Form 3938

Drug Master File (DMF) Submissions on New FDA Form 3938

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018

Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018

Requirement for Electronic Submission of an Application and Study Data - REdI 2020

Requirement for Electronic Submission of an Application and Study Data - REdI 2020

GCP & Pharmacovigilance Compliance Symposium | D2S06 – Panel Discussion

GCP & Pharmacovigilance Compliance Symposium | D2S06 – Panel Discussion

Medical Device Quality Management System Regulation Design and Development

Medical Device Quality Management System Regulation Design and Development

OTC Monograph Reform: OTC Sunscreen Drugs

OTC Monograph Reform: OTC Sunscreen Drugs

Preclinical Considerations for Cell and Gene Therapy Products, an FDA Perspective

Preclinical Considerations for Cell and Gene Therapy Products, an FDA Perspective

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Components of New Drug Application and Biologics License Application (5of15) REdI– May 29-30, 2019

Components of New Drug Application and Biologics License Application (5of15) REdI– May 29-30, 2019

FDA Expert Panel on Testosterone Replacement Therapy for Men

FDA Expert Panel on Testosterone Replacement Therapy for Men